Breaking Down the Latest Decision in the Purdue Pharma Case
Andrew Behlmann, partner in the firm’s Bankruptcy & Restructuring Department, breaks down last week’s decision by SDNY Judge McMahon to vacate confirmation of Purdue Pharma’s chapter 11 plan. Behlmann discusses the 142-page written opinion as well as the chapter 11 plan’s third-party releases, and provides insightful background on one of the most widely publicized and scrutinized chapter 11 bankruptcy cases in history.
Speakers:
Andrew Behlmann, Partner, Bankruptcy & Restructuring Department
Lowenstein Bankruptcy Lowdown
Attorneys in the firm’s Bankruptcy & Restructuring Department break down recent decisions and other key bankruptcy industry news and events.